| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. | Chief Technology Officer | Stock Option (right to buy) | 153,129 | 02 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HOWL | Werewolf Therapeutics, Inc. | 02 Jan 2025 | 2 | $0 | 4 | Chief Technology Officer | 06 Jan 2025, 17:43 |
| HOWL | Werewolf Therapeutics, Inc. | 02 Jan 2024 | 1 | $0 | 4 | Chief Technology Officer | 04 Jan 2024, 16:30 |
| HOWL | Werewolf Therapeutics, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Chief Technology Officer | 09 Jan 2023, 20:35 |
| HOWL | Werewolf Therapeutics, Inc. | 01 Jun 2022 | 1 | $0 | 4 | Chief Technology Officer | 03 Jun 2022, 16:40 |
| HOWL | Werewolf Therapeutics, Inc. | 06 Jan 2022 | 1 | $0 | 4 | Chief Technology Officer | 18 Jan 2022, 17:29 |
| HOWL | Werewolf Therapeutics, Inc. | 01 Jul 2021 | 1 | $0 | 4 | Chief Technology Officer | 02 Jul 2021, 08:26 |
| HOWL | Werewolf Therapeutics, Inc. | 14 Jun 2021 | 0 | $0 | 3 | Chief Technology Officer | 15 Jun 2021, 07:53 |